Skip to main content
. 2016 Sep 20;2016(9):CD011756. doi: 10.1002/14651858.CD011756.pub2

Summary of findings for the main comparison. Comparison of plasma transfusions versus no plasma transfusions when the INR is 1.5 prior to central venous catheter insertion.

Comparison of plasma transfusions versus no plasma transfusions
Patient or population: people with abnormal coagulation requiring a central venous catheter
 Setting: In hospital
 Intervention: prophylactic plasma transfusion
 Comparison: no plasma transfusions
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) № of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Risk with no plasma transfusions Risk with prophylactic plasma transfusion
Major procedure‐related bleedingfollow‐up: 24 hours There were no major procedure‐related bleeds in either of the study arms Not
estimable
58
(1 RCT)
⊕⊝⊝⊝
 VERY LOW 1 2  
All‐cause mortalityfollow‐up: 30 days   Not
reported
Respiratory deterioration attributable to transfusion‐associated circulatory overload (TACO), transfusion‐related acute lung injury (TRALI) or transfusion‐associated dyspnoea (TAD) Not
reported
Minor procedure‐related bleedingfollow‐up: 24 hours Study population RR 0.67
 (0.12 to 3.70) 58
 (1 RCT) ⊕⊝⊝⊝
 VERY LOW 2 3  
103 per 1000 69 per 1000
 (12 to 383)
Proportion of participants receiving plasma transfusions Not
reported
Line‐related complications Not
reported
Quality of life Not
reported
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 
 CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidenceHigh quality: We are very confident that the true effect lies close to that of the estimate of the effect
 Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
 Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Downgraded by 2 for very serious imprecision. The included study was a small study and this is a rare outcome with no events in either study arm

2 Downgraded by 1 for serious risk of bias. There was a high risk of performance bias and other bias

3 Downgraded by 2 for very serious imprecision. The included study was a small study and the 95% confidence interval of the risk ratio includes the possibility of significant harm or significant benefit.